000904383 001__ 904383
000904383 005__ 20230123101905.0
000904383 0247_ $$2doi$$a10.2967/jnumed.120.253450
000904383 0247_ $$2ISSN$$a0022-3123
000904383 0247_ $$2ISSN$$a0097-9058
000904383 0247_ $$2ISSN$$a0161-5505
000904383 0247_ $$2ISSN$$a1535-5667
000904383 0247_ $$2ISSN$$a2159-662X
000904383 0247_ $$2Handle$$a2128/32273
000904383 0247_ $$2pmid$$a33334911
000904383 0247_ $$2WOS$$aWOS:000621928600004
000904383 037__ $$aFZJ-2021-05953
000904383 082__ $$a610
000904383 1001_ $$0P:(DE-HGF)0$$aWahl, Richard L.$$b0$$eCorresponding author
000904383 245__ $$aMars Shot for Nuclear Medicine, Molecular Imaging, and Molecularly Targeted Radiopharmaceutical Therapy
000904383 260__ $$aNew York, NY$$bSoc.$$c2021
000904383 3367_ $$2DRIVER$$aarticle
000904383 3367_ $$2DataCite$$aOutput Types/Journal article
000904383 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1667392712_31190
000904383 3367_ $$2BibTeX$$aARTICLE
000904383 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000904383 3367_ $$00$$2EndNote$$aJournal Article
000904383 520__ $$aAbstractThe Society of Nuclear Medicine and Molecular Imaging created the Value Initiative in 2017 as a major component of its strategic plan to further demonstrate the value of molecular imaging and molecularly targeted radiopharmaceutical therapy to patients, physicians, payers, and funding agencies. The research and discovery domain, 1 of 5 under the Value Initiative, has a goal of advancing the research and development of diagnostic and therapeutic nuclear medicine. Research and discovery efforts and achievements are essential to ensure a bright future for NM and to translate science to practice. Given the remarkable progress in the field, leaders from the research and discovery domain and society councils identified 5 broad areas of opportunity with potential for substantive growth and clinical impact. This article discusses these 5 growth areas, identifying specific areas of particularly high importance for future study and development. As there was an understanding that goals should be both visionary yet achievable, this effort was called the Mars shot for nuclear medicine.Keywords: artificial intelligence; molecular imaging; neuroimaging; radiopharmaceutical therapy; theranostics.
000904383 536__ $$0G:(DE-HGF)POF4-5253$$a5253 - Neuroimaging (POF4-525)$$cPOF4-525$$fPOF IV$$x0
000904383 588__ $$aDataset connected to CrossRef, Journals: juser.fz-juelich.de
000904383 7001_ $$0P:(DE-HGF)0$$aChareonthaitawee, Panithaya$$b1
000904383 7001_ $$0P:(DE-HGF)0$$aClarke, Bonnie$$b2
000904383 7001_ $$0P:(DE-Juel1)177611$$aDrzezga, Alexander$$b3
000904383 7001_ $$0P:(DE-HGF)0$$aLindenberg, Liza$$b4
000904383 7001_ $$0P:(DE-HGF)0$$aRahmim, Arman$$b5
000904383 7001_ $$0P:(DE-HGF)0$$aThackeray, James$$b6
000904383 7001_ $$0P:(DE-HGF)0$$aUlaner, Gary A.$$b7
000904383 7001_ $$0P:(DE-HGF)0$$aWeber, Wolfgang$$b8
000904383 7001_ $$0P:(DE-HGF)0$$aZukotynski, Katherine$$b9
000904383 7001_ $$0P:(DE-HGF)0$$aSunderland, John$$b10$$eCorresponding author
000904383 773__ $$0PERI:(DE-600)2040222-3$$a10.2967/jnumed.120.253450$$gVol. 62, no. 1, p. 6 - 14$$n1$$p6 - 14$$tJournal of nuclear medicine$$v62$$x0022-3123$$y2021
000904383 8564_ $$uhttps://juser.fz-juelich.de/record/904383/files/6.full.pdf$$yOpenAccess
000904383 909CO $$ooai:juser.fz-juelich.de:904383$$pdnbdelivery$$pdriver$$pVDB$$popen_access$$popenaire
000904383 9101_ $$0I:(DE-HGF)0$$6P:(DE-HGF)0$$a Mallinckrodt Institute of Radiology, Washington University St. Louis, Missouri$$b0
000904383 9101_ $$0I:(DE-HGF)0$$6P:(DE-HGF)0$$a Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota$$b1
000904383 9101_ $$0I:(DE-HGF)0$$6P:(DE-HGF)0$$a  Research and Discovery, Society of Nuclear Medicine and Molecular Imaging, Reston, Virginia$$b2
000904383 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)177611$$aForschungszentrum Jülich$$b3$$kFZJ
000904383 9101_ $$0I:(DE-HGF)0$$6P:(DE-Juel1)177611$$a  Department of Nuclear Medicine, University of Cologne, Cologne, Germany$$b3
000904383 9101_ $$0I:(DE-HGF)0$$6P:(DE-Juel1)177611$$a German Center for Neurodegenerative Diseases, Bonn-Cologne, Germany$$b3
000904383 9101_ $$0I:(DE-HGF)0$$6P:(DE-HGF)0$$a  Molecular Imaging Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland$$b4
000904383 9101_ $$0I:(DE-HGF)0$$6P:(DE-HGF)0$$a Departments of Radiology and Physics, University of British Columbia, Vancouver, British Columbia, Canada$$b5
000904383 9101_ $$0I:(DE-HGF)0$$6P:(DE-HGF)0$$a Department of Integrative Oncology, BC Cancer Research Institute, Vancouver, British Columbia, Canada$$b5
000904383 9101_ $$0I:(DE-HGF)0$$6P:(DE-HGF)0$$a  Department of Nuclear Medicine, Hannover Medical School, Hannover, Germany$$b6
000904383 9101_ $$0I:(DE-HGF)0$$6P:(DE-HGF)0$$a Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York$$b7
000904383 9101_ $$0I:(DE-HGF)0$$6P:(DE-HGF)0$$a Molecular Imaging and Therapy, Hoag Cancer Center, Newport Beach, California$$b7
000904383 9101_ $$0I:(DE-HGF)0$$6P:(DE-HGF)0$$a Department of Nuclear Medicine, Technical University Munich, Munich, Germany$$b8
000904383 9101_ $$0I:(DE-HGF)0$$6P:(DE-HGF)0$$a Departments of Medicine and Radiology, McMaster University, Hamilton, Ontario, Canada$$b9
000904383 9101_ $$0I:(DE-HGF)0$$6P:(DE-HGF)0$$a Departments of Radiology and Physics, University of Iowa, Iowa City, Iowa$$b10
000904383 9131_ $$0G:(DE-HGF)POF4-525$$1G:(DE-HGF)POF4-520$$2G:(DE-HGF)POF4-500$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$9G:(DE-HGF)POF4-5253$$aDE-HGF$$bKey Technologies$$lNatural, Artificial and Cognitive Information Processing$$vDecoding Brain Organization and Dysfunction$$x0
000904383 9141_ $$y2022
000904383 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2021-01-27
000904383 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2021-01-27
000904383 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2021-01-27
000904383 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2021-01-27
000904383 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2021-01-27
000904383 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bJ NUCL MED : 2019$$d2021-01-27
000904383 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2021-01-27
000904383 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2021-01-27
000904383 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2021-01-27
000904383 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
000904383 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bJ NUCL MED : 2019$$d2021-01-27
000904383 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2021-01-27
000904383 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central$$d2021-01-27
000904383 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2021-01-27
000904383 920__ $$lyes
000904383 9201_ $$0I:(DE-Juel1)INM-2-20090406$$kINM-2$$lMolekulare Organisation des Gehirns$$x0
000904383 980__ $$ajournal
000904383 980__ $$aVDB
000904383 980__ $$aUNRESTRICTED
000904383 980__ $$aI:(DE-Juel1)INM-2-20090406
000904383 9801_ $$aFullTexts